CN112690351B - Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof - Google Patents
Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof Download PDFInfo
- Publication number
- CN112690351B CN112690351B CN202011570031.2A CN202011570031A CN112690351B CN 112690351 B CN112690351 B CN 112690351B CN 202011570031 A CN202011570031 A CN 202011570031A CN 112690351 B CN112690351 B CN 112690351B
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- flower
- millettia speciosa
- tea beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013616 tea Nutrition 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims description 14
- 241000521581 Millettia Species 0.000 title description 3
- 241001098027 Callerya speciosa Species 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 210000004369 blood Anatomy 0.000 claims abstract description 24
- 239000008280 blood Substances 0.000 claims abstract description 24
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 16
- 241000572565 Alpinia oxyphylla Species 0.000 claims abstract description 14
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 10
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 10
- 235000000346 sugar Nutrition 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 241000628997 Flos Species 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000004806 packaging method and process Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000007865 diluting Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 241000723353 Chrysanthemum Species 0.000 abstract description 15
- 238000000855 fermentation Methods 0.000 abstract description 5
- 230000004151 fermentation Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 244000141218 Alpinia officinarum Species 0.000 abstract description 2
- 239000001774 alpinia officinarum Substances 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 210000002966 serum Anatomy 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000012467 final product Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 6
- 230000000055 hyoplipidemic effect Effects 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 235000020339 pu-erh tea Nutrition 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 241000993291 Armillariella Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241001164374 Calyx Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention provides a composition for preparing a blood sugar and blood fat reducing tea beverage, which comprises the following components: 40-50 parts of radix millettiae speciosae, 20-30 parts of alpinia oxyphylla flower, 10-20 parts of galangal flower, 10-20 parts of chrysanthemum and 40-50 parts of puer tea. The invention also provides the millettia speciosa champ-alpinia oxyphylla tea drink prepared by adopting the composition through fermentation. The invention takes the millettia speciosa, the alpinia oxyphylla flower, the alpinia officinarum flower, the chrysanthemum and the puer tea as the combination, and after fermentation, the components complement each other and cooperate, so that the invention has good effects of reducing blood sugar, reducing blood fat and the like, and the invention keeps the fragrance of the tea, has faint scent and delicious taste, is convenient to drink and is easy to adhere.
Description
Technical Field
The invention belongs to the technical field of beverages, and particularly relates to a millettia speciosa champ-alpinia oxyphylla tea beverage and a preparation method and application thereof.
Background
With increasing living standard, we have put a higher wish for health. For people with normal weight, the body balance is hoped to be maintained, and the obesity is worried about causing different diseases. For people who are in need of weight loss, especially women, like beauty, the weight loss is expected to be beautiful and healthy. For patient groups with hyperlipidemia and hyperglycemia, it is desirable that the blood lipid and blood glucose be stable every day. At present, serious public health problems such as obesity, hyperlipidemia, diabetes and the like are faced in China, and the health care tea is particularly obvious in middle-aged and elderly people. Treatment for obesity generally employs diet therapy, exercise therapy, and pharmacotherapy. Diet therapy is a method of controlling body weight by suppressing the total intake of energy, and even if weight loss is successful, it causes physical problems such as malnutrition and frequent hunger sensation to the patient, and is a method which cannot be used for a long period of time. When exercise therapy is adopted, continuous and intense oxygen consumption exercise is required, and the exercise is difficult to adhere to. Most weight-losing medicines are in drug therapy, and have different degrees of toxic and side effects on the body after taking, so that the weight-losing medicine is not suitable for long-term taking. For the treatment of hyperlipidemia and diabetes, chemical drugs can generate toxic and side effects of different degrees, and the diseases are easy to recur after stopping the drugs, so that a method for treating and conditioning the hyperlipidemia and the diabetes by using simple chemical drugs is not suitable.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides a millettia speciosa champ-alpinia oxyphylla tea beverage and a preparation method and application thereof.
The first aspect of the invention provides a composition for preparing a blood sugar-reducing and blood fat-reducing tea beverage, which comprises the following components in parts by weight:
40-50 parts of calyx seu fructus physalis, such as 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts, 50 parts,
20-30 parts of alpinia oxyphylla flowers, for example 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts, 30 parts,
10-20 parts of galangal flower, for example 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts,
10-20 parts of chrysanthemum, for example 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts,
40-50 parts of puer tea, such as 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts and 50 parts.
Preferably, the components of the composition comprise, in parts by weight: 45 parts of radix millettiae speciosae, 25 parts of alpinia oxyphylla flower, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of puer tea.
If not specified, the alpinia oxyphylla flower in the invention is dried alpinia oxyphylla flower which is steamed in a water-proof way and then is sun-dried until being completely dehydrated.
If not specified, the galangal flowers in the invention are dried galangal flowers which are completely dehydrated after being steamed in a water-proof manner and then being sun-dried.
The chrysanthemum is dried chrysanthemum obtained by steaming fresh chrysanthemum in a water-proof way, and then sun-drying until the chrysanthemum is completely dehydrated.
The Pu' er tea is prepared from Yunnan big leaf species sun-dried raw tea according to the traditional process (tidal water (water content is less than or equal to 30%), pile fermentation (temperature is less than 60 ℃), pile turning, deblocking, tedding, screening, checking and finished product).
The millettia speciosa champ is a traditional Chinese medicine millettia speciosa champ unless otherwise specified.
In a second aspect, the invention provides a millettia speciosa champ-alpinia oxyphylla tea beverage prepared by fermenting the composition according to the first aspect of the invention.
In a third aspect, the invention provides a method for preparing the millettia speciosa champ-alpinia oxyphylla tea beverage according to the second aspect, which comprises the following steps:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 2-5 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 20-30min;
(3) Fermenting at 35-40deg.C for 3-5 days;
(4) Filtering to obtain filtrate.
Wherein, the millettia speciosa champ-alpinia oxyphylla tea beverage can be prepared into a finished liquid beverage to be directly drunk, and at the moment, the preparation method also comprises the steps of (5) adding water to dilute the finished product and the composition according to the first aspect of the invention to a ratio of 40-50ml to 1g, sub-packaging and sterilizing.
Wherein the millettia speciosa champ-alpinia oxyphylla tea beverage can be prepared into solid powder, and is added with water for mixing when being drunk, and the preparation method further comprises the step of concentrating and drying in the step (5).
In a fourth aspect, the invention provides the use of a composition according to the first aspect of the invention, or a Oriental millettia root-alpinia oxyphylla tea beverage according to the second aspect of the invention, in the preparation of a hypoglycemic and/or hypolipidemic product.
The invention takes the millettia speciosa, the alpinia oxyphylla flower, the alpinia officinarum flower, the chrysanthemum and the puer tea as the combination, and after fermentation, the components complement each other and cooperate, so that the invention has good effects of reducing blood sugar, reducing blood fat and the like, and the invention keeps the fragrance of the tea, has faint scent and delicious taste, is convenient to drink and is easy to adhere.
Detailed Description
The invention will be further described with reference to specific examples to provide a better understanding of the invention. The specific techniques or conditions are not identified in the examples and are performed according to techniques or conditions described in the literature in this field or according to the product specifications. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
If not specified, the alpinia oxyphylla flowers are dried alpinia oxyphylla flowers which are steamed in a water-proof way and then sun-dried until completely dehydrated, the chrysanthemum flowers are dried chrysanthemum flowers which are steamed in a water-proof way and then sun-dried until completely dehydrated, the Pu' er tea is prepared from Yunnan big leaf species sun-dried raw tea according to the traditional process (tidal water (water content is less than or equal to 30%), pile fermentation (temperature is less than 60 ℃), pile turning, deblocking, tedding, screening, inspection and finished product, and the radix millettiae speciosa championii is a traditional Chinese medicine radix millettiae speciosa championii.
Example 1
The millettia speciosa champ-alpinia oxyphylla tea beverage is prepared from a composition for preparing the hypoglycemic and hypolipidemic tea beverage, and the composition comprises the following components in parts by weight: 45 parts of radix millettiae speciosae, 25 parts of alpinia oxyphylla flower, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of puer tea.
The preparation method comprises the following steps:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 3 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 4 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and the composition of this example at a ratio of 50ml:1g, packaging, and sterilizing.
Example 2
The millettia speciosa champ-alpinia oxyphylla tea beverage is prepared from a composition for preparing the hypoglycemic and hypolipidemic tea beverage, and the composition comprises the following components in parts by weight: 50 parts of radix millettiae speciosae, 20 parts of alpinia oxyphylla flowers, 20 parts of galangal flowers, 10 parts of chrysanthemum and 50 parts of puer tea.
The preparation method comprises the following steps:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 4 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 20min;
(3) Fermenting at 35-40deg.C for 3 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and the composition of this example at a ratio of 50ml:1g, packaging, and sterilizing.
Example 3
The millettia speciosa champ-alpinia oxyphylla tea beverage is prepared from a composition for preparing the hypoglycemic and hypolipidemic tea beverage, and the composition comprises the following components in parts by weight: 40 parts of millettia speciosa, 30 parts of alpinia oxyphylla flower, 10 parts of galangal flower, 20 parts of chrysanthemum and 40 parts of puer tea.
The preparation method comprises the following steps:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 2 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 5 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product at a ratio of 40 ml/1 g, packaging, and sterilizing.
Comparative example 1
This comparative example differs from example 1 in that the components of the composition do not contain oregano, and the method of preparation is:
(1) Taking puer tea, adding a proper amount of water, and boiling for 3 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 4 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and composition of this comparative example at a ratio of 50 ml/1 g, packaging, and sterilizing.
Comparative example 2
This comparative example differs from example 1 in that the composition does not contain alpinia oxyphylla in its components, and is prepared by:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 3 hours;
(2) Adding rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 4 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and composition of this comparative example at a ratio of 50 ml/1 g, packaging, and sterilizing.
Comparative example 3
The comparative example differs from example 1 in that the components of the composition do not contain galangal flowers and chrysanthemums, and the preparation method is as follows:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 3 hours;
(2) Adding flos Alpinae Oxyphyllae, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 4 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and composition of this comparative example at a ratio of 50 ml/1 g, packaging, and sterilizing.
Comparative example 4
The comparative example is different from example 1 in that the components of the composition do not contain Pu' er tea, and the preparation method is as follows:
(1) Adding proper amount of water into the radix et rhizoma Rhei powder, and boiling for 3 hr;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 30min;
(3) Fermenting at 35-40deg.C for 4 days;
(4) Filtering, and collecting filtrate;
(5) Diluting with water to give final product and composition of this comparative example at a ratio of 50 ml/1 g, packaging, and sterilizing.
Hypolipidemic animal experiments
1) The millettia speciosa champ-alpinia oxyphylla tea drink of the embodiment 1 of the invention is used as a sample, and the tea drinks of the comparative examples 1 to 4 are used as a reference.
2) Experimental animals: SD healthy SPF male rats were selected.
3) Dosage is as follows: the test group (inventive example 1) and the control group 1-4 (inventive comparative examples 1-4) were orally administered to rats according to a lavage volume of 0.5mL/100g of the rat weight, and each index was measured after continuous lavage for 30 days three times a day. And a blank group is arranged at the same time, and water is used for replacing the tea beverage.
4) The formula of the high-fat feed comprises the following components: 78.8% of basic feed, 1% of cholesterol, 10% of yolk powder, 10% of lard and 0.2% of bile salt by weight. The basic feed is produced by the breeding field of the Armillariella volvacea of Jiang Ningou in Nanjing.
5) The experimental method comprises the following steps: after rats are fed with the high-fat feed for 7-10 days, detecting the total serum cholesterol (TC) value and the total serum Triglyceride (TG) value of the fasting rats, selecting 60 rats with the total serum cholesterol value reaching above 7.0mmol/L and the total serum triglyceride reaching above 2.0mmol/L, randomly dividing the rats into 6 groups, and feeding the rats with basic feed instead:
experimental group: the tea beverage of example 1 of the present invention was filled,
control group 1: the tea beverage of comparative example 1 of the present invention was filled with stomach,
control group 2: the tea beverage of comparative example 2 of the present invention was filled with stomach,
control group 3: gavage the tea beverage of comparative example 3 of the present invention,
control group 4: the tea beverage of comparative example 4 of the present invention was filled with stomach,
blank group: and (5) pouring gastric juice.
Serum total cholesterol and triglycerides were measured in each group of rats, 30 days after administration of the tea drink of the present invention, after 16 hours of fasting.
6) Serum total cholesterol, triglyceride assay
Blood is taken, centrifugation is carried out for 10 minutes at 3000r/min, serum is separated, the serum is taken and measured by a SELECTRA-E full-automatic biochemical analyzer, and the total cholesterol and triglyceride content of the serum can be measured, and the results are shown in Table 1.
Table 1 (average value)
As can be seen from Table 1, the differences between the serum total cholesterol and the triglyceride of the experimental group and the control group 1-4 before the administration of the tea drink of the present invention were not significant, while the serum total cholesterol and the triglyceride of the experimental group were significantly reduced compared with the control group 1-4 and the blank group after 30 days of the administration of the tea drink of the present invention. From the experimental results, the tea beverage provided by the invention has a good blood lipid reducing function.
Blood sugar reducing animal experiment
1) The millettia speciosa champ-alpinia oxyphylla tea drink of the embodiment 1 of the invention is used as a sample, and the tea drinks of the comparative examples 1 to 4 are used as a reference.
2) Experimental animals: healthy C57BL male mice weighing (22.sup.2) g were selected.
3) Dosage is as follows: the test group (inventive example 1) and the control group 1-4 (inventive comparative examples 1-4) were orally administered to rats according to a lavage volume of 0.5mL/100g of the rat weight, and each index was measured after continuous lavage for 30 days three times a day. And a blank group is arranged at the same time, and water is used for replacing the tea beverage.
4) The formula of the high-sugar and high-fat feed comprises the following components: 66.5% of basic feed, 2.5% of cholesterol, 20% of white granulated sugar, 10% of lard and 1% of bile salt by weight. The basic feed is produced by the breeding field of the Armillariella volvacea of Jiang Ningou in Nanjing.
5) The experimental method comprises the following steps: after mice are fed with high-sugar and high-fat feed for 20-30 days, fasting blood glucose changes are detected, 60 mice with the blood glucose value more than or equal to 14.9mmol/L are selected, and are randomly divided into 6 groups, and then basic feed is fed:
experimental group: the tea beverage of example 1 of the present invention was filled,
control group 1: the tea beverage of comparative example 1 of the present invention was filled with stomach,
control group 2: the tea beverage of comparative example 2 of the present invention was filled with stomach,
control group 3: gavage the tea beverage of comparative example 3 of the present invention,
control group 4: the tea beverage of comparative example 4 of the present invention was filled with stomach,
blank group: and (5) pouring gastric juice.
The change in fasting blood glucose was measured 30 days after administration of the tea beverage of the present invention, after 16 hours of fasting.
6) Serum blood glucose determination
Blood was collected, centrifuged at 3000r/min for 10 minutes to separate serum, and the blood glucose level was measured by GT-1810 glucometer, and the results are shown in Table 2.
Table 2 (average value, unit:)
As can be seen from table 2, before the administration of the tea beverage of the present invention, the serum Total Cholesterol (TC), triglyceride (TG) and the blank of the experimental group and the control group 1 to 4 were not significantly different, and after the administration of the tea beverage of the present invention for 30 days, the blood glucose value of the experimental group and the control group 1 to 4 and the blank of the experimental group were significantly reduced. From the experimental results, the tea beverage provided by the invention has a good blood sugar reducing function.
The above description of the specific embodiments of the present invention has been given by way of example only, and the present invention is not limited to the above described specific embodiments. Any equivalent modifications and substitutions for the present invention will occur to those skilled in the art, and are also within the scope of the present invention. Accordingly, equivalent changes and modifications are intended to be included within the scope of the present invention without departing from the spirit and scope thereof.
Claims (3)
1. The application of the millettia speciosa champ-alpinia oxyphylla tea beverage in preparing the products for reducing blood sugar and/or blood fat is characterized in that the millettia speciosa champ-alpinia speciosa champ beverage is prepared by fermenting a composition of the blood sugar-reducing and blood fat-reducing tea beverage, and the composition comprises the following components in parts by weight: 45 parts of radix millettiae speciosae, 25 parts of alpinia oxyphylla flower, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of puer tea;
the preparation method of the millettia speciosa champ-alpinia oxyphylla tea beverage comprises the following steps:
(1) Taking puer tea and millettia speciosa champ powder, adding a proper amount of water, and boiling for 2-5 hours;
(2) Adding flos Alpinae Oxyphyllae, rhizoma Alpiniae Officinarum flower and flos Chrysanthemi, and decocting for 20-30min;
(3) Fermenting at 35-40deg.C for 3-5 days;
(4) Filtering to obtain filtrate.
2. The use according to claim 1, further comprising the steps of (5) diluting with water to a final ratio of product to composition of 40-50ml:1g, packaging, and sterilizing.
3. The use according to claim 1, further comprising a step (5) of concentrating and drying.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011570031.2A CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011570031.2A CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112690351A CN112690351A (en) | 2021-04-23 |
| CN112690351B true CN112690351B (en) | 2023-10-27 |
Family
ID=75511096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011570031.2A Active CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112690351B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| CN104172312A (en) * | 2014-08-21 | 2014-12-03 | 武汉旭东食品有限公司 | Iced tea melon seeds and production method thereof |
| CN104621296A (en) * | 2013-11-11 | 2015-05-20 | 南京拓鉒医药科技有限公司 | Blood lipid, glucose and pressure regulating traditional Chinese medicine combined tea drink |
| CN106173125A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of looks improving and the skin nourishing nutrition chocolate and preparation method thereof |
| CN107439751A (en) * | 2017-10-14 | 2017-12-08 | 蓝本祥 | A kind of preparation method of beautiful millettia root tea beverage |
| CN109652202A (en) * | 2019-01-22 | 2019-04-19 | 陈子久 | A kind of intelligence development safflower tea oil and preparation method thereof |
| CN110477159A (en) * | 2019-09-12 | 2019-11-22 | 三亚市林业科学研究院 | A kind of preparation method of intelligence development jasmine tea and its intelligence development jasmine tea of preparation |
-
2020
- 2020-12-26 CN CN202011570031.2A patent/CN112690351B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| CN104621296A (en) * | 2013-11-11 | 2015-05-20 | 南京拓鉒医药科技有限公司 | Blood lipid, glucose and pressure regulating traditional Chinese medicine combined tea drink |
| CN104172312A (en) * | 2014-08-21 | 2014-12-03 | 武汉旭东食品有限公司 | Iced tea melon seeds and production method thereof |
| CN106173125A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of looks improving and the skin nourishing nutrition chocolate and preparation method thereof |
| CN107439751A (en) * | 2017-10-14 | 2017-12-08 | 蓝本祥 | A kind of preparation method of beautiful millettia root tea beverage |
| CN109652202A (en) * | 2019-01-22 | 2019-04-19 | 陈子久 | A kind of intelligence development safflower tea oil and preparation method thereof |
| CN110477159A (en) * | 2019-09-12 | 2019-11-22 | 三亚市林业科学研究院 | A kind of preparation method of intelligence development jasmine tea and its intelligence development jasmine tea of preparation |
Non-Patent Citations (1)
| Title |
|---|
| 高良姜提取物的降血糖活性;王辉等;《热带生物学报》;20140625;第5卷(第2期);第179-181页；第181页第1段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112690351A (en) | 2021-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538664A (en) | Compositions of ginsenoside Rg3 and ginsenoside Rg5 and their pharmaceutical uses, including antitumor effects | |
| CN102228180A (en) | Betelnut buccal tablet and preparation method thereof | |
| CN102551065A (en) | Blood sugar reducing food series | |
| CA2871478C (en) | Pleuropterus multiflorus extract and dipsacus asperoides extract for stimulating the secretion of insulin-like growth factor and promoting bone structure growth, and method for preparing same | |
| CN100395325C (en) | Aloe grape dry red wine and its preparation method | |
| CN109985086B (en) | Cyclocarya paliurus leaf instant powder and preparation method thereof | |
| CN102499414A (en) | Method for preparing eucommia ulmoies leaf and wolfberry beverage | |
| JP2012526801A (en) | Composition for improving blood circulation containing fermented tea extract, pharmaceutical composition and fermented tea composition containing fermented tea extract | |
| CN110226688A (en) | A kind of mulberries rhizoma polygonati drink and preparation method thereof | |
| JPH10508880A (en) | Pharmaceutical composition for diabetes | |
| CN112690351B (en) | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof | |
| CN111592959A (en) | Tonic three-penis wine and extraction method thereof | |
| EP1369123A1 (en) | A health-care product comprising lotus rhizome and process for its preparation | |
| CN114145374A (en) | Astragalus membranaceus and corn stigma composite tea and preparation method and application thereof | |
| CN110393218B (en) | Juicy peach and peanut compound flavor yoghourt rich in multiple functional factors and preparation method thereof | |
| CN112754014A (en) | Composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN114533817A (en) | Composition for improving blood sugar and/or blood fat and application thereof | |
| CN108936577A (en) | A kind of compound group preparation method of the edible natural with cardiovascular protective effect | |
| KR102691530B1 (en) | Method for increasing anti-obesity compounds of fruits of Cudrania tricuspidata and a composition for improving and preventing obesity comprising the increased anti-obesity compounds | |
| CN115400189B (en) | Glycolipid-coordinated traditional Chinese medicine composition, extract, preparation method, application and preparation | |
| CN107312692A (en) | A kind of production method of Golden flower bitter buckwheat wine | |
| CN102613339B (en) | Ginkgo garlic pu-erh fermented tea composite particle drink | |
| CN108260818A (en) | It is a kind of with reducing blood lipid, hypoglycemic, blood pressure lowering, the health food and preparation method thereof for improving immunity function | |
| CN115536522A (en) | Use of pachyman cortex extract, pachyman neo-acid A and pachyman neo-acid B for regulating blood sugar | |
| KR20100060857A (en) | Veronicastrum sibiricum extracts for improving insulin resistance and products containing them as effective ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |